A citation-based method for searching scientific literature

Anne Sophie V M van den Heerik, Nanda Horeweg, Stephanie M de Boer, Tjalling Bosse, Carien L Creutzberg. Int J Gynecol Cancer 2021
Times Cited: 16







List of co-cited articles
66 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy.
Alicia León-Castillo, Stephanie M de Boer, Melanie E Powell, Linda R Mileshkin, Helen J Mackay, Alexandra Leary, Hans W Nijman, Naveena Singh, Pamela M Pollock, Paul Bessette,[...]. J Clin Oncol 2020
135
43

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.
Nicole Concin, Xavier Matias-Guiu, Ignace Vergote, David Cibula, Mansoor Raza Mirza, Simone Marnitz, Jonathan Ledermann, Tjalling Bosse, Cyrus Chargari, Anna Fagotti,[...]. Int J Gynecol Cancer 2021
252
37

PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer.
Anne Sophie V M van den Heerik, Nanda Horeweg, Remi A Nout, Ludy C H W Lutgens, Elzbieta M van der Steen-Banasik, G Henrike Westerveld, Hetty A van den Berg, Annerie Slot, Friederike L A Koppe, Stefan Kommoss,[...]. Int J Gynecol Cancer 2020
42
31

Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies.
Thomas Hogberg, Mauro Signorelli, Carlos Freire de Oliveira, Roldano Fossati, Andrea Alberto Lissoni, Bengt Sorbe, Håkan Andersson, Seija Grenman, Caroline Lundgren, Per Rosenberg,[...]. Eur J Cancer 2010
304
31

Integrated genomic characterization of endometrial carcinoma.
Cyriac Kandoth, Nikolaus Schultz, Andrew D Cherniack, Rehan Akbani, Yuexin Liu, Hui Shen, A Gordon Robertson, Itai Pashtan, Ronglai Shen, Christopher C Benz,[...]. Nature 2013
31

Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer.
Marcus E Randall, Virginia Filiaci, D Scott McMeekin, Vivian von Gruenigen, Helen Huang, Catheryn M Yashar, Robert S Mannel, Jae-Weon Kim, Ritu Salani, Paul A DiSilvestro,[...]. J Clin Oncol 2019
134
31

Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts.
Ellen Stelloo, Remi A Nout, Elisabeth M Osse, Ina J Jürgenliemk-Schulz, Jan J Jobsen, Ludy C Lutgens, Elzbieta M van der Steen-Banasik, Hans W Nijman, Hein Putter, Tjalling Bosse,[...]. Clin Cancer Res 2016
313
25

Clinical actionability of molecular targets in endometrial cancer.
Mary Ellen Urick, Daphne W Bell. Nat Rev Cancer 2019
116
25

Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomas.
Alicia León-Castillo, Ester Gilvazquez, Remi Nout, Vincent Thbm Smit, Jessica N McAlpine, Melissa McConechy, Stefan Kommoss, Sara Y Brucker, Joseph W Carlson, Elisabeth Epstein,[...]. J Pathol 2020
91
25

Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer.
Daniela Matei, Virginia Filiaci, Marcus E Randall, David Mutch, Margaret M Steinhoff, Paul A DiSilvestro, Katherine M Moxley, Yong M Kim, Matthew A Powell, David M O'Malley,[...]. N Engl J Med 2019
159
25

Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial.
R Maggi, A Lissoni, F Spina, M Melpignano, P Zola, G Favalli, A Colombo, R Fossati. Br J Cancer 2006
296
25

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.
Stephanie M de Boer, Melanie E Powell, Linda Mileshkin, Dionyssios Katsaros, Paul Bessette, Christine Haie-Meder, Petronella B Ottevanger, Jonathan A Ledermann, Pearly Khaw, Alessandro Colombo,[...]. Lancet Oncol 2018
247
25

CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence.
Katherine C Kurnit, Grace N Kim, Bryan M Fellman, Diana L Urbauer, Gordon B Mills, Wei Zhang, Russell R Broaddus. Mod Pathol 2017
125
18

A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study.
Henry M Keys, James A Roberts, Virginia L Brunetto, Richard J Zaino, Nick M Spirtos, Jeffrey D Bloss, Andrew Pearlman, Mitchell A Maiman, Jeffrey G Bell. Gynecol Oncol 2004
18

Uterine Cancer Incidence and Mortality - United States, 1999-2016.
S Jane Henley, Jacqueline W Miller, Nicole F Dowling, Vicki B Benard, Lisa C Richardson. MMWR Morb Mortal Wkly Rep 2018
93
18

A clinically applicable molecular-based classification for endometrial cancers.
A Talhouk, M K McConechy, S Leung, H H Li-Chang, J S Kwon, N Melnyk, W Yang, J Senz, N Boyd, A N Karnezis,[...]. Br J Cancer 2015
348
18

Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.
Marcus E Randall, Virginia L Filiaci, Hyman Muss, Nick M Spirtos, Robert S Mannel, Jeffrey Fowler, J Tate Thigpen, Jo Ann Benda. J Clin Oncol 2006
608
18

Endometrial Cancer.
Karen H Lu, Russell R Broaddus. N Engl J Med 2020
127
18


Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy.
B G Wortman, C L Creutzberg, H Putter, I M Jürgenliemk-Schulz, J J Jobsen, L C H W Lutgens, E M van der Steen-Banasik, J W M Mens, A Slot, M C Stenfert Kroese,[...]. Br J Cancer 2018
99
12

Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial cancer.
Mariam M AlHilli, Andrea Mariani, Jamie N Bakkum-Gamez, Sean C Dowdy, Amy L Weaver, Preema P Peethambaram, Gary L Keeney, William A Cliby, Karl C Podratz. Gynecol Oncol 2014
54
12

Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials.
Tjalling Bosse, Elke E M Peters, Carien L Creutzberg, Ina M Jürgenliemk-Schulz, Jan J Jobsen, Jan Willem M Mens, Ludy C H W Lutgens, Elzbieta M van der Steen-Banasik, Vincent T H B M Smit, Remi A Nout. Eur J Cancer 2015
158
12

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up.
N Colombo, C Creutzberg, F Amant, T Bosse, A González-Martín, J Ledermann, C Marth, R Nout, D Querleu, M R Mirza,[...]. Ann Oncol 2016
514
12

L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation.
Alain G Zeimet, Daniel Reimer, Monica Huszar, Boris Winterhoff, Ulla Puistola, Samira Abdel Azim, Elisabeth Müller-Holzner, Alon Ben-Arie, Léon C van Kempen, Edgar Petru,[...]. J Natl Cancer Inst 2013
139
12


Prognostic significance of lymphovascular space invasion in low-risk endometrial cancer.
Ali Ayhan, Hanifi Şahin, Mustafa Erkan Sari, Ibrahim Yalçin, Ali Haberal, Mehmet Mutlu Meydanli. Int J Gynecol Cancer 2019
9
22

Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series.
S Kommoss, M K McConechy, F Kommoss, S Leung, A Bunz, J Magrill, H Britton, F Kommoss, F Grevenkamp, A Karnezis,[...]. Ann Oncol 2018
214
12

Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative.
Ellen Stelloo, Tjalling Bosse, Remi A Nout, Helen J MacKay, David N Church, Hans W Nijman, Alexandra Leary, Richard J Edmondson, Melanie E Powell, Emma J Crosbie,[...]. Mod Pathol 2015
232
12

Endometrial cancer.
Philippe Morice, Alexandra Leary, Carien Creutzberg, Nadeem Abu-Rustum, Emile Darai. Lancet 2016
812
12

Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer.
Jeong-Yeol Park, Seok Ju Seong, Tae-Jin Kim, Jae Weon Kim, Seok Mo Kim, Duk-Soo Bae, Joo-Hyun Nam. Obstet Gynecol 2013
62
12


The Growing Burden of Endometrial Cancer: A Major Racial Disparity Affecting Black Women.
Michele L Cote, Julie J Ruterbusch, Sara H Olson, Karen Lu, Rouba Ali-Fehmi. Cancer Epidemiol Biomarkers Prev 2015
110
12

L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile.
Felix Kf Kommoss, Anthony N Karnezis, Friedrich Kommoss, Aline Talhouk, Florin-Andrei Taran, Annette Staebler, C Blake Gilks, David G Huntsman, Bernhard Krämer, Sara Y Brucker,[...]. Br J Cancer 2018
45
12

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up.
Nicoletta Colombo, Carien Creutzberg, Frederic Amant, Tjalling Bosse, Antonio González-Martín, Jonathan Ledermann, Christian Marth, Remi Nout, Denis Querleu, Mansoor Raza Mirza,[...]. Int J Gynecol Cancer 2016
322
12

Incorporation of molecular characteristics into endometrial cancer management.
Lisa Vermij, Vincent Smit, Remi Nout, Tjalling Bosse. Histopathology 2020
70
12

Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta-analysis.
Jessica N McAlpine, Derek S Chiu, Remi A Nout, David N Church, Pascal Schmidt, Stephanie Lam, Samuel Leung, Stefania Bellone, Adele Wong, Sara Y Brucker,[...]. Cancer 2021
15
13

Cancer of the corpus uteri.
Frédéric Amant, Mansoor Raza Mirza, Martin Koskas, Carien L Creutzberg. Int J Gynaecol Obstet 2018
174
12

Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations.
Robert W Holloway, Nadeem R Abu-Rustum, Floor J Backes, John F Boggess, Walter H Gotlieb, W Jeffrey Lowery, Emma C Rossi, Edward J Tanner, Rebecca J Wolsky. Gynecol Oncol 2017
184
12


Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis.
Amanda N Fader, Dana M Roque, Eric Siegel, Natalia Buza, Pei Hui, Osama Abdelghany, Setsuko Chambers, Angeles Alvarez Secord, Laura Havrilesky, David M O'Malley,[...]. Clin Cancer Res 2020
53
12

Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas.
Marthe M de Jonge, Aurélie Auguste, Lise M van Wijk, Philip C Schouten, Matty Meijers, Natalja T Ter Haar, Vincent T H B M Smit, Remi A Nout, Mark A Glaire, David N Church,[...]. Clin Cancer Res 2019
68
12

Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial.
Stephanie M de Boer, Melanie E Powell, Linda Mileshkin, Dionyssios Katsaros, Paul Bessette, Christine Haie-Meder, Petronella B Ottevanger, Jonathan A Ledermann, Pearly Khaw, Romerai D'Amico,[...]. Lancet Oncol 2019
162
12

Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.
Aline Talhouk, Melissa K McConechy, Samuel Leung, Winnie Yang, Amy Lum, Janine Senz, Niki Boyd, Judith Pike, Michael Anglesio, Janice S Kwon,[...]. Cancer 2017
300
12

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
12

Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209).
David S Miller, Virginia L Filiaci, Robert S Mannel, David E Cohn, Takashi Matsumoto, Krishnansu S Tewari, Paul DiSilvestro, Michael L Pearl, Peter A Argenta, Matthew A Powell,[...]. J Clin Oncol 2020
49
12

Clinical Activity and Safety of the Anti-Programmed Death 1 Monoclonal Antibody Dostarlimab for Patients With Recurrent or Advanced Mismatch Repair-Deficient Endometrial Cancer: A Nonrandomized Phase 1 Clinical Trial.
Ana Oaknin, Anna V Tinker, Lucy Gilbert, Vanessa Samouëlian, Cara Mathews, Jubilee Brown, Maria-Pilar Barretina-Ginesta, Victor Moreno, Adriano Gravina, Cyril Abdeddaim,[...]. JAMA Oncol 2020
73
12

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma.
C L Creutzberg, W L van Putten, P C Koper, M L Lybeert, J J Jobsen, C C Wárlám-Rodenhuis, K A De Winter, L C Lutgens, A C van den Bergh, E van de Steen-Banasik,[...]. Lancet 2000
12

Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu.
Amanda N Fader, Dana M Roque, Eric Siegel, Natalia Buza, Pei Hui, Osama Abdelghany, Setsuko K Chambers, Angeles Alvarez Secord, Laura Havrilesky, David M O'Malley,[...]. J Clin Oncol 2018
175
12

Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.
R A Nout, V T H B M Smit, H Putter, I M Jürgenliemk-Schulz, J J Jobsen, L C H W Lutgens, E M van der Steen-Banasik, J W M Mens, A Slot, M C Stenfert Kroese,[...]. Lancet 2010
685
12

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.
Gini F Fleming, Virginia L Brunetto, David Cella, Katherine Y Look, Gary C Reid, Adnan R Munkarah, Richard Kline, Robert A Burger, Annekathryn Goodman, R Tucker Burks. J Clin Oncol 2004
387
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.